Gain-of-function mutations of NLRP3 are known to cause syndromic hearing loss in systemic autoinflammatory diseases- CAPS and autosomal dominant non-syndromic hearing loss locus (DFNA43) in patients [38, 47]. Here, NLRP3 is linked to hearing loss disorder.